Perspectives of nanofibrous wound dressings based on glucans and galactans - A review.

Carbohydrate dressings Electrospinning Infection Nanostructured smart dressings Physio-chemical and mechanical properties Wound healing

Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
31 Jul 2023
Historique:
received: 08 12 2022
revised: 06 06 2023
accepted: 10 06 2023
medline: 17 7 2023
pubmed: 18 6 2023
entrez: 17 6 2023
Statut: ppublish

Résumé

Wound healing is a complex and dynamic process that needs an appropriate environment to overcome infection and inflammation to progress well. Wounds lead to morbidity, mortality, and a significant economic burden, often due to the non-availability of suitable treatments. Hence, this field has lured the attention of researchers and pharmaceutical industries for decades. As a result, the global wound care market is expected to be 27.8 billion USD by 2026 from 19.3 billion USD in 2021, at a compound annual growth rate (CAGR) of 7.6 %. Wound dressings have emerged as an effective treatment to maintain moisture, protect from pathogens, and impede wound healing. However, synthetic polymer-based dressings fail to comprehensively address optimal and quick regeneration requirements. Natural polymers like glucan and galactan-based carbohydrate dressings have received much attention due to their inherent biocompatibility, biodegradability, inexpensiveness, and natural abundance. Also, nanofibrous mesh supports better proliferation and migration of fibroblasts because of their large surface area and similarity to the extracellular matrix (ECM). Thus, nanostructured dressings derived from glucans and galactans (i.e., chitosan, agar/agarose, pullulan, curdlan, carrageenan, etc.) can overcome the limitations associated with traditional wound dressings. However, they require further development pertaining to the wireless determination of wound bed status and its clinical assessment. The present review intends to provide insight into such carbohydrate-based nanofibrous dressings and their prospects, along with some clinical case studies.

Identifiants

pubmed: 37330091
pii: S0141-8130(23)02252-3
doi: 10.1016/j.ijbiomac.2023.125358
pii:
doi:

Substances chimiques

Galactans 0
Polymers 0
Glucans 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

125358

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sachin Latiyan (S)

Department of Metallurgical and Materials Engineering, Indian Institute of Technology Madras, Chennai 600036, India; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India.

T S Sampath Kumar (TSS)

Department of Metallurgical and Materials Engineering, Indian Institute of Technology Madras, Chennai 600036, India. Electronic address: tssk@iitm.ac.in.

Mukesh Doble (M)

Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India; Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai 600077, India.

John F Kennedy (JF)

Chembiotech Labs, Institute of Science and Technology, Kyrewood House, Tenbury Wells WR158FF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH